With a robust history in private equity, the fund manager has executed over 200 deals, primarily across the technology and healthcare sectors. Active in both growth and buyout stages, their strategic style leans towards data-driven investment, focusing on companies in Europe and North America. Notable exits include several high-profile IPOs, reflecting a strong track record of value creation and market foresight. Their approach emphasizes thematic investing, identifying trends that shape the future landscape of targeted industries.